Session Datesort ascending
Enhancing the Diagnosis of the Primary Aldosteronism Syndrome/High-Specific-Activity Iodine 131 Metaiodobenzylguanidine for the Treatment of Advanced Pheochromocytoma and Paraganglioma: A Real-World Study, Multicentric Retrospective Evaluation 06/03/2022 - 12:00pm to 1:00pm CDT
Endocrine Targets Under Investigation for Management of HIV-associated Metabolic Dysfunction/Inpatient Hypoglycemia Standing Order Protocol/In Men on Testosterone Therapy, Baseline Testosterone Level of <264 ng/dl is Associated with Greater Improvement i 05/20/2022 - 12:00pm to 1:00pm CDT
Cardiovascular Disease in HIV: Physiologic Insights Derived from the Renin-Angiotensin-Aldosterone System 04/15/2022 - 12:00pm to 1:00pm CDT
The Role of Biomechanics in Evaluating the Benefit of Lifestyle Intervention Therapy 04/01/2022 - 12:00pm to 1:00pm CDT
Spotlight on Cardiometabolic Disease and Its Implications for Diabetes Management 03/18/2022 - 12:00pm to 1:00pm CDT
The Metabolic Consequences of Reactivated Developmental Signals in Obesity 03/04/2022 - 12:00pm to 1:00pm CST
What Evolution, Physics, and Machine Learning Tell About Diabetes Type 2 Genomes 02/25/2022 - 12:00pm to 1:00pm CST
Why Do Beta Cells Fail in Type 2 Diabetes? 02/04/2022 - 12:00pm to 1:00pm CST
Glucocorticoid Stress Dosing: Current Practices versus Pharmacokinetics Data 01/21/2022 - 12:00pm to 1:00pm CST
Primary Aldosteronism: A Simplified Approach to a Common Cause of Hypertension/Standing Order Protocol for Inpatient Treatment of Hypoglycemia 01/07/2022 - 12:00pm to 1:00pm CST